PHUOC NGO: Open Payments
NPI 1154992428 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 50 payments from 16 companies in 2025. Trend: 2023 $965 · 2024 $1,297 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $232 |
| Lilly USA, LLC | 7 | $122 |
| Exact Sciences Corporation | 5 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $58 |
| ABIOMED | 2 | $55 |
| Amgen Inc. | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
Products named: Ozempic, MOUNJARO, Cologuard Collection Kit, JARDIANCE, XIFAXAN, Wegovy, REXULTI, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
